Coda Biotherapeutics

OverviewSuggest Edit

Coda Biotherapeutics is a biotechnology company which provides a chemogenetic platform that aims to control the activity of cells to treat a disease. The Company develops a chemogenetic treatment to modulate neuronal activity. Its main product includes non-native safe, orally bioavailable drugs which activate or silence the targeted neurons, depending on the receptor used. The drugs allow curing neuropathic pains, epilepsy, movement disorders, and other nervous system disorders.  

TypePrivate
Founded2014
HQSouth San Francisco, CA, US
Websitecodabiotherapeutics.com

Locations

Coda Biotherapeutics is headquartered in
South San Francisco, United States

Location Map

Latest Updates

Employees (est.) (Sept 2021)29(+8%)
Cybersecurity ratingAMore

Key People/Management at Coda Biotherapeutics

Michael Narachi

Michael Narachi

President, Chief Executive Officer and Board Director
Steven Dodson

Steven Dodson

Vice President, Pharmacology and Early Development
Tom Woiwode

Tom Woiwode

Director
H. Finer

H. Finer

Co-Founder, Board Director, and Compensation Committee Chair
Marcelo Bigal

Marcelo Bigal

Director
Show more

Coda Biotherapeutics Office Locations

Coda Biotherapeutics has an office in South San Francisco
South San Francisco, CA, US (HQ)
329 Oyster Point Blvd 3rd Floor
South San Francisco, CA, US
121 Oyster Point Blvd
Show all (2)

Coda Biotherapeutics Financials and Metrics

Summary Metrics

Founding Date

2014

Coda Biotherapeutics total Funding

$34 m

Coda Biotherapeutics latest funding size

$15 m

Time since last funding

2 years ago

Coda Biotherapeutics investors

Coda Biotherapeutics's latest funding round in November 2019 was reported to be $15 m. In total, Coda Biotherapeutics has raised $34 m
Show all financial metrics

Coda Biotherapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Coda Biotherapeutics Online and Social Media Presence

Embed Graph

Coda Biotherapeutics Frequently Asked Questions

  • When was Coda Biotherapeutics founded?

    Coda Biotherapeutics was founded in 2014.

  • Who are Coda Biotherapeutics key executives?

    Coda Biotherapeutics's key executives are Michael Narachi, Steven Dodson and Tom Woiwode.

  • How many employees does Coda Biotherapeutics have?

    Coda Biotherapeutics has 29 employees.

  • Who are Coda Biotherapeutics competitors?

    Competitors of Coda Biotherapeutics include Aptinyx, Neurotech and Generation Bio.

  • Where is Coda Biotherapeutics headquarters?

    Coda Biotherapeutics headquarters is located at 329 Oyster Point Blvd 3rd Floor, South San Francisco.

  • Where are Coda Biotherapeutics offices?

    Coda Biotherapeutics has an office in South San Francisco.

  • How many offices does Coda Biotherapeutics have?

    Coda Biotherapeutics has 2 offices.